BusinessUSFDA Issues 7 Observations to Emcure Pharma After Gujarat Inspection
Emcure Pharmaceuticals announced that the US Food and Drug Administration (USFDA) completed a current Good Manufacturing Practices (cGMP) inspection of its Gujarat plant, resulting in seven observations. The company disclosed these findings on May 16 from New Delhi, highlighting regulatory scrutiny of its manufacturing processes.
Menafn··Gujarat


